On November 1, 2023 ALX Oncology Holdings Inc., ("ALX Oncology") (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, reported that management will participate in three upcoming investor conferences in November (Press release, ALX Oncology, NOV 1, 2023, View Source [SID1234636620]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2023 UBS BioPharma Conference
Format: Fireside chat with analyst, Dr. Colin Bristow
Date: Wednesday, November 8th
Time: 1:30 PM EST
Location: Miami Beach, FL
Webcast link: Available here

2023 Jefferies London Healthcare Conference
Format: Fireside chat with analyst, Michael Yee
Date: Tuesday, November 14th
Time: 3:00 PM GMT
Location: London, UK
Webcast link: Available here

2023 Piper Sandler Healthcare Conference
Format: Fireside chat with analyst, Christopher Raymond
Date: Tuesday, November 28th
Time: 4:30 PM EST
Location: New York, NY
Webcast link: Available here

The live webcasts for the UBS, Jefferies and Piper Sandler fireside chats can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com and selecting Events under the News and Events tab. A replay of the webcast will be archived for up to 90 days following the fireside chat date.